Overview

Observation of Patients With Transfusional Hemosiderosis Treatment With Deferasirox

Status:
Completed
Trial end date:
2015-10-01
Target enrollment:
Participant gender:
Summary
This study will observe patients with transfusional hemosiderosis treated with deferasirox in actual practice setting.
Details
Lead Sponsor:
Novartis Pharmaceuticals
Treatments:
Deferasirox